Physician profile
Patrick W Shovlin
NPI 1003908500
$19,016.43
in general payments reported to CMS, 2019-2025
25 companies · $8,066 in 2025
The $8,066 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,807 · 2020: $248 · 2021: $301 · 2022: $405 · 2023: $1,093 · 2024: $96.66 · 2025: $8,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Travel and Lodging: $717 · Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Travel and Lodging | $717.35 |
| Food and Beverage | $538.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,676.33 | 2019-2025 | |
| Medical Device Business Services, INC. | $903.83 | 2023 | Linx Reflux Management System |
| Allergan, INC. | $370.51 | 2019-2022 | |
| Ethicon US, LLC | $206.37 | 2019-2024 | Stratafix, Ethicon, Linx Reflux Management System |
| Medtronic, INC. | $131.44 | 2021-2024 | Signia, Parietene Ds, Progrip |
| Davol INC. | $128.33 | 2019-2025 | Phasix Mesh |
| Tela Bio, INC. | $92.50 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $69.16 | 2020-2022 | |
| Abbvie INC. | $63.88 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Integra Lifesciences Corporation | $60.24 | 2021 | |
| Innocoll Pharmaceuticals Limited | $43.84 | 2021 | |
| Kci USA, INC. | $35.47 | 2021 | |
| Access Pro Medical, LLC | $24.66 | 2022 | |
| Ambu INC. | $23.97 | 2023 | |
| Monaghan Medical Corporation | $23.58 | 2023 | Aeroeclipse |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $23.32 | 2024 | Irrisept |
| Conmed Corporation | $21.64 | 2025 | Airseal |
| Baudax Bio INC. | $18.53 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $17.76 | 2022 | |
| Sanara Medtech INC. | $16.88 | 2022 | |
| Smith+Nephew, INC. | $14.70 | 2021 | |
| Trevena, INC. | $14.10 | 2022 | |
| Covidien LP | $12.38 | 2019 | |
| Acell, INC. | $11.59 | 2019 | |
| Teleflex LLC | $11.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Shovlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.